The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients
Open Access
- 1 July 2015
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 138 (1), 154-158
- https://doi.org/10.1016/j.ygyno.2015.04.040
Abstract
No abstract availableKeywords
Funding Information
- The Dorene Knapp Ovarian Cancer Fund
- CCKMA Ovarian Cancer Fund
This publication has 21 references indexed in Scilit:
- Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS)Gynecologic Oncology, 2014
- Prevalence of Childhood and Adult Obesity in the United States, 2011-2012JAMA, 2014
- Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology, 2012
- Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2Gynecologic Oncology, 2009
- Dosing chemotherapy in obese patients: Actual versus assigned body surface area (BSA)Cancer Treatment Reviews, 2008
- Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trialAnnals Of Oncology, 2008
- Evaluation of Alternate Size Descriptors for Dose Calculation of Anticancer Drugs in the ObeseJournal of Clinical Oncology, 2007
- Quantitative Effect of Gender, Age, Liver Function, and Body Size on the Population Pharmacokinetics of Paclitaxel in Patients with Solid TumorsClinical Cancer Research, 2006
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- Dose: A critical factor in cancer chemotherapyAmerican Journal Of Medicine, 1980